Detection of Left Ventricular Hypertrophy by Different Electrocardiographic Criteria in Clinical Practice. Findings From the Sara Study

REFERENCES

• Barrios V, Escobar C, Calderón A, Echarri R, González-Pedel V, Ruilope LM. Cardiovascular risk profile and risk stratification of the hypertensive population attended by general practitioners and specialists in Spain. The CONTROL RISK study. J Hum Hypertens 2007;21:479–485.
   PubMed Web of Science ®Google Scholar
• Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990;322:1561–1566.
   PubMed Web of Science ®Google Scholar
• Verdecchia P, Schillacci G, Borgioni C, Prognostic significance of serial changes in left ventricular mass in essential hypertension. Circulation 1998;97:48–54.
   PubMed Web of Science ®Google Scholar
• Okin PM, Devereaux RB, Julius J, Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol. The LIFE Study. Circulation 2003;108:684–690.
   PubMed Web of Science ®Google Scholar
• Verdecchia P, Angeli F, Borgioni C, Changes in cardiovascular risk by reduction of left ventricular mass in hypertension: A meta-analysis. Am J Hypertens 2003;16:895–899.
   PubMed Web of Science ®Google Scholar
• Mathew J, Sleight P, Lonn E, Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril. Circulation 2001;104:1615–1621.
   PubMed Web of Science ®Google Scholar
• Okin PM, Devereaux RB, Julius J, Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of mayor cardiovascular events. JAMA 2004;292:2343–2349.
   PubMed Web of Science ®Google Scholar
• Klingbeil AV, Schneider M, Martus P, Messerli FH, Schmieder RE. A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension. Am J Med 2003;115:41–46.
   PubMed Web of Science ®Google Scholar
• Devereux RB, Dahlöf B, Gerdts E, Regression of hypertensive left ventricular hypertorphy by losartan compared with atenolol. The Losartan Intervention For Endpoint (LIFE) reduction in hypertensive study. Circulation 2004;110:1456–1462.
   PubMed Web of Science ®Google Scholar
• Schneider MP, Klingbeil AU, Delles C, Effect of irbesartan versus atenolol on left ventricular mass and voltage: Results of the Cardiovascular Irbesartan Project. Hypertension 2004;44:61–66.
   PubMed Web of Science ®Google Scholar
• European Society of Hypertension/European Society of Cardiology. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007;25:1105–1187.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Juanatey JR, Mazón P, Soria F, 2003 update of the Guidelines of the Spanish Society of Cardiology on High Blood Pressure. Rev Esp Cardiol 2003;56:487–497.
   PubMed Web of Science ®Google Scholar
• Evangelista A, Alonso AM, Martín R, Clinical practice guidelines of the Spanish Society of Cardiology on echocardiography. Rev Esp Cardiol 2000;53:663–683.
   PubMed Web of Science ®Google Scholar
• Molloy TJ, Okin PM, Devereux RB, Kligfield P. Electrocardiographic detection of left ventricular hypertrophy by the simple QRS voltage-duration product. J Am Coll Cardiol 1992;20:1180–1186.
   PubMed Web of Science ®Google Scholar
• Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Dählof B for the LIFE Study Investigators. Baseline characteristics in relation to electrocardiographic left ventricular hypertrophy in hypertensive patients: the losartan intervention for endpoint (LIFE) reduction in hypertension study. Hypertension 2000;36:766–773.
   PubMed Web of Science ®Google Scholar
• Barrios V, Calderon A, Escobar C, Electrocardiographic left ventricular hypertrophy regression induced by an angiotensin receptor blocker-based regimen in daily clinical practice. The SARA study. J Hypertens 2007;25:1967–1973.
   PubMed Web of Science ®Google Scholar
• Okin PM, Roman MJ, Devereaux RB, Kligfield P. Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products. J Am Coll Cardiol 1995;25:417–423.
   PubMed Web of Science ®Google Scholar
• Okin PM, Roman MJ, Devereux RB, Pickering TG, Borer JS, Kligfield P. Time-voltage area of the 12-lead electrocardiogram. Detection of left ventricular hypertrophy. Hypertension 1998;31:937–942.
   PubMed Web of Science ®Google Scholar
• Lozano JV, Redón J, Cea-Calvo L, Left ventricular hypertrophy in the Spanish hypertensive population. The ERIC-HTA study. Rev Esp Cardiol 2006;59:136–142.
   PubMed Web of Science ®Google Scholar
• Pascual JM, Rodilla E, González C, Pérez-Hoyos S, Redon J. Long term impact of systolic blood pressure and glicemia on the development of microalbuminuria in essential hipertensión. Hipertensión 2005;45:1125–1130.
   PubMed Web of Science ®Google Scholar
• Llisterri JL, Rodríguez-Roca GC, Alonso FJ, Blood pressure control in Spanish hypertensive patients in primary health care centres. PRESCAP 2002 Study. Med Clin (Barc) 2004;122:165–171.
   PubMed Web of Science ®Google Scholar
• González-Juanatey JR, Cea-Calvo L, Bertomeu V, Aznar J. Electrocardiographic criteria for left ventricular hypertrophy and cardiovascular risk in hypertensives. VIIDA study. Rev Esp Cardiol 2007;60:148–156.
   PubMed Web of Science ®Google Scholar
• Dhingra R, Ho Nam B, Benjamin EJ, Cross-sectional relations of electrocardiographic QRS duration to left ventricular dimensions. The Framingham Heart Study. J Am Coll Cardiol 2005;45:685–689.
   PubMed Web of Science ®Google Scholar
• Barrios V, Escobar C, Calderon A, Regression of left ventricular hypertrophy by a candesartan-based regimen in clinical practice. The VIPE Study. J Renin Angiotensin Aldosterone Syst 2006;7:236–242.
   PubMed Web of Science ®Google Scholar
• Verdecchia P, Angeli F, Reboldi G, Improved cardiovascular risk stratification by a simple ECG index in hipertensión. Am J Hypertens 2003;16:646–652.
   PubMed Web of Science ®Google Scholar
• Dahlof B, Devereux RB, Julius J, The losartan intervention for endpoint reduction (LIFE) in Hypertension study: Rationale, design and methods. The LIFE Study Group. Am J Hypertens 1997;10:705–713.
   PubMed Web of Science ®Google Scholar
• Alfakih K, Walters K, Jones T, Ridgway J, Hall AS, Sivananthan M. New gender-specific partition values for ECG criteria of left ventricular hypertrophy. Recalibration against cardiac MRI. Hypertension 2004;44:175–179.
   PubMed Web of Science ®Google Scholar
• Okin PM, Wright JT, Nieminen MS, Ethnic differences in electrocardiographic criteria for left ventricular hypertrophy: The LIFE study. Losartan intervention for endpoint. Am J Hypertens 2002;15:663–671.
   PubMed Web of Science ®Google Scholar
• Devereux RB, Palmieri V, Liu JE, Progressive hypertrophy regression with sustained pressure reduction in hypertension: The losartan intervention for endpoint reduction study. J Hypertens 2002;20:1445–1450.
   PubMed Web of Science ®Google Scholar
• Verdecchia P, Porcellati C, Reboldi G, Left ventricular hypertrophy as an independient predictor of acute cerebrovascular events in essential hypertension. Circulation 2001;104:2039–2044.
   PubMed Web of Science ®Google Scholar
• Coca A, Gabriel R, de la Figuera M, The impact of different echocardiographic diagnostic criteria on the prevalence of left ventricular hypertrophy in essential hypertension: The VITAE study. Ventriculo Izquierdo Tension Arterial Espana. J Hypertens 1999;17:1471–1480.
   PubMed Web of Science ®Google Scholar
• Martinez MA, Sancho T, Armada E, Prevalence of left ventricular hypertrophy in patients with mild hypertension in primary care: impact of echocardiography on cardiovascular risk stratification Am J Hypertens 2003;16:556–563.
   PubMed Web of Science ®Google Scholar
• Sokolow M, Lyon TP. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J 1949;37:161–186.
   PubMed Web of Science ®Google Scholar
• Casale PN, Devereaux RB, Alonso DR, Campo E, Kliegfield P. Improved sex-specific criteria of left ventricular hypertrophy for clinical and computer interpretation of electrocardiograms: validation with autopsy findings. Circulation 1987;75:565–572.
   PubMed Web of Science ®Google Scholar